Table 1.
Demographic and clinical characteristics, number of electroconvulsive therapy (ECT) sessions, and changes in symptoms. We evaluated depressive symptoms using the Hamilton Depression Rating Scale (HAM‐D) at baseline <1 wk before the first ECT session (HAM‐D Pre ECT) and within 1 wk after one full ECT cycle (HAM‐D Post ECT)
| Gender | Age (y) | ECT number | HAM‐D Pre ECT | HAM‐D post ECT | Medication | |
|---|---|---|---|---|---|---|
| 1 | Female | 65 | 12 | 35 | 9 | Aripiprazole |
| 2 | Female | 66 | 13 | 28 | 0 | Sulpiride, trazodone, lorazepam, quetiapine |
| 3 | Female | 67 | 3 | 5 | 0 | Sertraline, olanzapine, bromazepam |
| 4 | Female | 68 | 14 | 27 | 16 | Mirtazapine, aripiprazole |
| 5 | Female | 68 | 10 | 19 | 1 | Olanzapine, duloxetine |
| 6 | Female | 69 | 5 | 31 | 19 | Free |
| 7 | Female | 74 | 13 | 18 | 7 | Trazodone, escitalopram, quetiapine |
| 8 | Female | 74 | 5 | 27 | 21 | Escitalopram |
| 9 | Female | 75 | 9 | 23 | 14 | Mirtazapine, sertraline |
| 10 | Male | 50 | 9 | 18 | 2 | Aripiprazole, mirtazapine, diazepam, olanzapine, trazodone, imipramine, escitalopram, levomepromazine |
| 11 | Male | 70 | 10 | 29 | 7 | Free |
| 12 | Male | 80 | 7 | 34 | 12 | Mianserin |
| Mean | 68.8 | 9.1 | 24.2 | 8.3 | ||
| SD | 7.3 | 3.5 | 8.8 | 7.4 |
ECT, electroconvulsive therapy; HAM‐D, Hamilton Depression Rating Scale; SD, standard deviation.